ARTICLE | Clinical News
Cytogen regulatory update
April 5, 1999 7:00 AM UTC
CYTO received U.S. Patent No. 5,885,577 covering antigen binding peptides (abtides) that bind to prostate specific membrane antigen ( PSMA), a human antigen associated with prostate and other cancers....